Cesca Therapeutics Inc., of Rancho Cordova, Calif., said it received a letter from Nasdaq stating that it does not comply with Nasdaq Listing Rule 5250(c)(1) because the regenerative medicine company has not yet filed its Form 10-Q for the period ended March 31.